Want to join the conversation?
Medical device company $ZBH said its 2015 sales rose 28.3%, driven by the Biomet merger. Volume/mix growth from the merger was partially offset by negative effects of changes in foreign currency exchange rates and pricing pressure in all geographic regions. Net earnings fell in 2015 due to the expense incurred related to the Biomet merger.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)